Initial Dual Oral coMbination Therapy Versus Standard-of-care Initial Oral Monotherapy Prior to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary hyperTension
Latest Information Update: 24 Jun 2024
At a glance
- Drugs Macitentan (Primary) ; Riociguat
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- Acronyms IMPACT-CTEPH
- 18 Jun 2024 Planned End Date changed from 31 Dec 2024 to 31 Dec 2025.
- 18 Jun 2024 Planned primary completion date changed from 30 Apr 2024 to 31 Dec 2024.
- 24 Oct 2022 Planned End Date changed from 15 Mar 2024 to 31 Dec 2024.